Ruxolitinib? Ruxolotinib is a common misspelling of ruxolitinib.
Ruxolitinib (Jakafi™) is prescribed to treat adults who have intermediate-risk or high-risk myelofibrosis, a rare bone marrow disease. This medication is designed to help prevent the formation of abnormal blood cells, which can enlarge the spleen and cause several symptoms in people with myelofibrosis.
The drug comes as a tablet that is taken twice daily. Although some people may not have any problems with this medicine, most people who receive ruxolitinib will experience some type of side effect. Common reactions include bruising, dizziness, and headaches.
(For more information on this medicine, click Ruxolitinib. This full-length article offers a complete overview of this drug, including how it works, safety warnings, and general dosing instructions. You can also click any of the links in the box to the right for more specific information.)
HealthSavvy Sign In
|